why choose us

First received: March 06, 2024

Clinical Trial: Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Solid Tumor

Study Type: INTERVENTIONAL


Official Title: Phase 1 Study to Evaluate the Mass Balance, Pharmacokinetics, Metabolism, Excretion and Absolute Bioavailability of Tuvusertib (M1774) Containing Microtracer 14C Tuvusertib in Participants With Advanc

Brief Summary: This is a single sequence 2-period open label study in participants with advanced solid tumors.The purpose of Period 1 of this study is to assess the mass balance to determine drug-related entities present in circulation and excreta and provide a comprehensive understanding of biotransformation pathways and clearance mechanisms in participants with advanced solid tumors.The purpose of Period 1a is to assess the extent of ABA of tuvusertib and the mass balance, PK, metabolism, and elimination of 14C-tuvusertib…

Read more